332 related articles for article (PubMed ID: 8762149)
21. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.
Bode W; Turk D; Karshikov A
Protein Sci; 1992 Apr; 1(4):426-71. PubMed ID: 1304349
[TBL] [Abstract][Full Text] [Related]
22. Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues.
Martin PD; Malkowski MG; DiMaio J; Konishi Y; Ni F; Edwards BF
Biochemistry; 1996 Oct; 35(40):13030-9. PubMed ID: 8855938
[TBL] [Abstract][Full Text] [Related]
23. Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes.
Mathews II; Padmanabhan KP; Ganesh V; Tulinsky A; Ishii M; Chen J; Turck CW; Coughlin SR; Fenton JW
Biochemistry; 1994 Mar; 33(11):3266-79. PubMed ID: 8136362
[TBL] [Abstract][Full Text] [Related]
24. Structure of a retro-binding peptide inhibitor complexed with human alpha-thrombin.
Tabernero L; Chang CY; Ohringer SL; Lau WF; Iwanowicz EJ; Han WC; Wang TC; Seiler SM; Roberts DG; Sack JS
J Mol Biol; 1995 Feb; 246(1):14-20. PubMed ID: 7853394
[TBL] [Abstract][Full Text] [Related]
25. Crystal structures of thrombin with thiazole-containing inhibitors: probes of the S1' binding site.
Matthews JH; Krishnan R; Costanzo MJ; Maryanoff BE; Tulinsky A
Biophys J; 1996 Nov; 71(5):2830-9. PubMed ID: 8913620
[TBL] [Abstract][Full Text] [Related]
26. Refined structure of the hirudin-thrombin complex.
Rydel TJ; Tulinsky A; Bode W; Huber R
J Mol Biol; 1991 Sep; 221(2):583-601. PubMed ID: 1920434
[TBL] [Abstract][Full Text] [Related]
27. Structure of the hirugen and hirulog 1 complexes of alpha-thrombin.
Skrzypczak-Jankun E; Carperos VE; Ravichandran KG; Tulinsky A; Westbrook M; Maraganore JM
J Mol Biol; 1991 Oct; 221(4):1379-93. PubMed ID: 1942057
[TBL] [Abstract][Full Text] [Related]
28. The crystal structures of human alpha-thrombin complexed with active site-directed diamino benzo[b]thiophene derivatives: a binding mode for a structurally novel class of inhibitors.
Chirgadze NY; Sall DJ; Briggs SL; Clawson DK; Zhang M; Smith GF; Schevitz RW
Protein Sci; 2000 Jan; 9(1):29-36. PubMed ID: 10739244
[TBL] [Abstract][Full Text] [Related]
29. Bound structures of novel P3-P1' beta-strand mimetic inhibitors of thrombin.
St Charles R; Matthews JH; Zhang E; Tulinsky A
J Med Chem; 1999 Apr; 42(8):1376-83. PubMed ID: 10212123
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure of human alpha-thrombin complexed with hirugen and p-amidinophenylpyruvate at 1.6 A resolution.
Chen Z; Li Y; Mulichak AM; Lewis SD; Shafer JA
Arch Biochem Biophys; 1995 Sep; 322(1):198-203. PubMed ID: 7574675
[TBL] [Abstract][Full Text] [Related]
31. Structure of the hirulog 3-thrombin complex and nature of the S' subsites of substrates and inhibitors.
Qiu X; Padmanabhan KP; Carperos VE; Tulinsky A; Kline T; Maraganore JM; Fenton JW
Biochemistry; 1992 Dec; 31(47):11689-97. PubMed ID: 1445905
[TBL] [Abstract][Full Text] [Related]
32. From natural to synthetic multisite thrombin inhibitors.
Lombardi A; De Simone G; Galdiero S; Staiano N; Nastri F; Pavone V
Biopolymers; 1999; 51(1):19-39. PubMed ID: 10380350
[TBL] [Abstract][Full Text] [Related]
33. Chemical compensation in macromolecular bridge-binding to thrombin.
Hopfner KP; Ayala Y; Szewczuk Z; Konishi Y; Di Cera E
Biochemistry; 1993 Mar; 32(12):2947-53. PubMed ID: 8457559
[TBL] [Abstract][Full Text] [Related]
34. Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.
Baum B; Muley L; Heine A; Smolinski M; Hangauer D; Klebe G
J Mol Biol; 2009 Aug; 391(3):552-64. PubMed ID: 19520086
[TBL] [Abstract][Full Text] [Related]
35. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
Bhunia SS; Roy KK; Saxena AK
J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
[TBL] [Abstract][Full Text] [Related]
36. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
[TBL] [Abstract][Full Text] [Related]
37. The crystal structure of alpha-thrombin-hirunorm IV complex reveals a novel specificity site recognition mode.
Lombardi A; De Simone G; Nastri F; Galdiero S; Della Morte R; Staiano N; Pedone C; Bolognesi M; Pavone V
Protein Sci; 1999 Jan; 8(1):91-5. PubMed ID: 10210187
[TBL] [Abstract][Full Text] [Related]
38. Inhibitor binding to thrombin: x-ray crystallographic studies.
Banner DW; Hadváry P
Adv Exp Med Biol; 1993; 340():27-33. PubMed ID: 8154341
[No Abstract] [Full Text] [Related]
39. Crystallographic structure of a peptidyl keto acid inhibitor and human alpha-thrombin.
Håkansson K; Tulinsky A; Abelman MM; Miller TA; Vlasuk GP; Bergum PW; Lim-Wilby MS; Brunck TK
Bioorg Med Chem; 1995 Aug; 3(8):1009-17. PubMed ID: 7582975
[TBL] [Abstract][Full Text] [Related]
40. Structures of thrombin complexes with a designed and a natural exosite peptide inhibitor.
Qiu X; Yin M; Padmanabhan KP; Krstenansky JL; Tulinsky A
J Biol Chem; 1993 Sep; 268(27):20318-26. PubMed ID: 8376390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]